Alba Dalmases

Hospital Del Mar — Spain

Medicine · Health Sciences

15h-index1.7kcitations63works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(36), Lung Cancer Treatments and Mutations(34), HER2/EGFR in Cancer Research(15), Cancer Genomics and Diagnostics(15), Radiomics and Machine Learning in Medical Imaging(12)

Publications63 total

Data from HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer
2023Open Access
Supplementary Data from HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer
2023Open Access
Data from HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer
2023Open Access
Supplementary Data from HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer
2023Open Access
Supplementary Table S1 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Data from The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer
2023Open Access
Supplementary Table and Figure Legends from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Data from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Table S2 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Figure S1 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Material from The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer
2023Open Access
Supplementary Table S3 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Figure S2 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Table S3 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Figure S3 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Material from The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer
2023Open Access
Supplementary Figure S2 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Table S2 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Table and Figure Legends from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
Supplementary Figure S3 from Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Joan Albanell(39), Beatríz Bellosillo(37), Ana Rovira(32), Clara Montagut(27), Mar Iglesias(26), Marta Salido(19), Israel Cañadas(15), Joaquim Bellmunt(14), Sabrina Arena(13), Giulia Siravegna(13), Alberto Bardelli(13), Oriol Arpí(12), Iria González(11), Elena Gavilán(11), Alejandro Martínez(11), Luca Lazzari(10), Noelia Ferruz(10), Mariangela Russo(10), Sandra Misale(10), Giorgio Corti(10)